A detailed history of Dcm Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Dcm Advisors, LLC holds 24,656 shares of PFE stock, worth $658,561. This represents 0.36% of its overall portfolio holdings.

Number of Shares
24,656
Previous 24,656 -0.0%
Holding current value
$658,561
Previous $689,000 3.48%
% of portfolio
0.36%
Previous 0.37%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $2.11 Million - $2.47 Million
-83,472 Reduced 77.2%
24,656 $689,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $6,446 - $7,402
249 Added 0.23%
108,128 $3 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $1.24 Million - $1.61 Million
47,358 Added 78.25%
107,879 $3.11 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $1,123 - $1,312
-35 Reduced 0.06%
60,521 $2.01 Million
Q2 2023

Sep 12, 2023

SELL
$36.12 - $41.79 $1,408 - $1,629
-39 Reduced 0.06%
60,556 $2.22 Million
Q1 2023

Sep 12, 2023

SELL
$39.39 - $51.28 $15,125 - $19,691
-384 Reduced 0.63%
60,595 $2.47 Million
Q4 2022

Sep 08, 2023

BUY
$41.75 - $54.5 $1.33 Million - $1.74 Million
31,933 Added 109.94%
60,979 $3.13 Million
Q3 2022

Sep 08, 2023

SELL
$43.76 - $53.42 $360,538 - $440,127
-8,239 Reduced 22.1%
29,046 $1.27 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $148,523 - $176,102
3,192 Added 9.36%
37,285 $1.96 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $137,341 - $170,183
-3,002 Reduced 8.09%
34,093 $1.77 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $507,326 - $752,027
12,278 Added 49.47%
37,095 $2.19 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $974,067 - $1.25 Million
24,817 New
24,817 $1.07 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Dcm Advisors, LLC Portfolio

Follow Dcm Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcm Advisors, LLC with notifications on news.